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In This IssueBrain Origami Master
PAGE 535
During evolution, the mammalian brain has undergone enormous expansion, with corre-
sponding changes in gyrification (folding). Stahl et al. show that levels of a DNA-associated
protein, Trnp1, determine whether the cortex expands tangentially or radially and also
regulate its gyrification. Trnp1 levels in the developing human brain correlate with regional
levels of folding.TNF Excess: TB or Not TB
PAGE 521
Tumor necrosis factor has been shown to be protective in tuberculosis. Roca and
Ramakrishnan find that excess TNF levels, however, induce mitochondrial ROS and lead
to macrophage necroptosis. This results in the lysis of infected macrophages and releaseof mycobacteria into the extracellular milieu, where they are able to grow unfettered. Pharmacological modulation of necroptosis
may help to preserve macrophage microbicidal activity and confer tuberculosis resistance to individuals with excess TNF.Cell Sorting Nixes Noise in Development
PAGE 550
Patterning and morphogenesis often occur concurrently in development. Using in toto imaging in the zebrafish neural tube, Xiong
et al. show that cell movements during morphogenesis create ‘‘noise’’ in the positional information encoded by the Sonic hedgehog
morphogen gradient. As a result, cells of different fates are specified in mixed and overlapping patterns. Fate-specific cell move-
ments then create sharp boundaries between cell-type domains. Thus, morphogenetic cell movements can both limit and correct
positional information.RNA Editor Meets RNA Silencer
PAGE 575
ADAR1 is a homodimeric RNA-editing enzyme that converts adenosine to inosine in dsRNA. Ota et al. now show that ADAR1 also
plays a completely different role as an RNAi regulator. When an ADAR1 monomer forms a complex with Dicer, it acts as an RNA
silencer by promoting miRNA processing, RISC loading, and RNAi efficacy. miRNA expression is globally suppressed in mouse
embryos lacking ADAR1, altering expression of miRNA targets and contributing to embryonic lethality.Vitamins Smack Down SMAD in Liver Injury
PAGE 601
Ding et al. show that vitamin D receptor (VDR) signaling inhibits liver fibrosis (scarring) by antagonizing the action of SMAD transcrip-
tional regulators in hepatic stellate cells. SMADs are activated by liver injury and, in the absence of VDR ligands, activate profibrotic
genes. However, they also enable their own repression bymaking the chromatin around their target sitesmore accessible to VDR that
will bind and inhibit SMAD activity in the presence of VDR ligands.Tanking the Proteasome
PAGE 614Selective protein degradation by the ubiquitin-proteasome system plays a vital role in
cellular homeostasis. Defects in this process are associated with various human diseases,
and the proteasome is a validated drug target in cancer therapy. Cho-Park and Steller
show that Tankyrase-mediated ADP-ribosylation of PI31 activates proteasomes by
promoting 26S proteasome assembly and that this process can be blocked with
Tankyrase-inhibitors. These results reveal a mechanism of proteasome regulation that
can be targeted with existing small-molecule inhibitors.miRNA Inhibition at the ER
PAGE 562
Translational repression is a conservedmode of action of plant and animal microRNAs, but
where it takes place subcellularly is unknown. Li et al. show that the integral ER membrane
protein AMP1 is required for translational repression of microRNA target transcripts and
inhibits their loading onto membrane-bound polysomes, indicating that the ER is an
important locus of translational repression.Cell 153, April 25, 2013 ª2013 Elsevier Inc. 495
Methyl Mark for Mismatch Repair
PAGE 590
DNA mismatch repair (MMR) maintains genome stability by correcting replication-generated
errors. Li et al. now show that a histone mark, H3K36me3, regulates MMR by directly interacting
with mismatch recognition protein MutSa and localizing it onto chromatin in G1 to early S phase,
before DNA replication. Cells lacking the H3K36 trimethyltransferase SETD2 display a mutator
phenotype similar to that caused by MutSa deficiency. This work explains the longstanding puz-
zle of MMR-deficient cancer cells that lack detectable mutations in MMR genes.
Domino Effect in Protease Ring
PAGE 628
The homohexameric AAA+ ATPase ClpX unfolds and translocates substrates into the ClpP pepti-
dase for degradation, but how ATP interacts with ClpX subunits is not known. Stinson et al. develop an assay to test the conforma-
tions and ATP-binding properties of individual subunits. They find that ClpX subunits convert between ATP-loadable and unloadable
during the functional cycle of ClpX and that ATP binding initiates stepwise allosteric changes in theClpX ring. The approach should be
applicable to the study of other multisubunit protein machines.
CLASH of the miRNAs
PAGE 654
miRNAs play many important regulatory roles, but their targets have been difficult to identify systematically. Helwak and colleagues
present an experimental approach termed CLASH, which allows identification of more than 18,000 interactions between miRNA and
mRNA molecules in human cells. The transcriptome-wide data set and accompanying functional studies show many noncanonical
interactions involving bulged or mismatched nucleotides, as well as interactions outside of the proposed 5’ "seed" region of miRNAs,
revealing a diversity of miRNA interaction modes and targets.
Weaving Together Cancer Genomes
PAGE 666
Genomic rearrangements drive cancer growth by creating oncogenic gene fusions and disrupting tumor suppressor genes. Baca
et al. sequence 57 prostate cancer genomes and model the genesis of chromosomal alterations based on thousands of detected
somatic rearrangements. Their model reveals interdependent rearrangements that shuffle DNA from five or more chromosomes in
a process that they term ‘‘chromoplexy’’ (from the Greek pleko, ‘‘to weave’’), suggesting that a few punctuated rounds of chromo-
plexy may suffice to induce the substantial derangement characteristic of cancer genomes.
Setting Sights on Cytosine Demethylation
PAGE 678 and PAGE 692
DNA demethylation involves oxidation of 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC), and 5-
carboxylcytosine (5caC) and subsequent excision of 5fC and 5caC by the DNA glycosylase TDG. Two papers now present methods
formapping the genome-wide locations of 5hmC, 5fC, and 5caC inmouse ESCs. Song et al. use selective chemical labeling and base
resolution to look at 5fC distribution, whereas Shen et al. employ modification-specific antibodies to detect all three forms. Together,
the two studies show that active cytosine demethylation occurs at multiple sites throughout the genome and is particularly prevalent
at poised enhancers, where 5fC accumulation correlates with increased binding of the transcriptional coactivator p300. The results
suggest a role for cytosine demethylation in the epigenetic tuning of regulatory elements.
Integrative Approach to AD Network
PAGE 707
Zhang et al. integrate transcriptional profiling of postmortem brains from late onset Alzheimer’s disease (AD) patients and controls,
with a rank-ordering and Bayesian inference approach to identify remodeled networks in the diseased brains and key nodes within
them. The results point toward a module for immune functions and microglial phagocytosis as an
important mechanism in AD pathology. The data provide a resource for probing themolecular un-
derpinnings of disease and may aid drug discovery efforts.
Off Switch for a Perpetually On Protein
PAGE 640
Signaling throughG proteins normally involves conformational switching betweenGTP- andGDP-
bound states. Rnd proteins are atypical constitutively GTP-bound Rho proteins, whose regulation
remains elusive. Now, Riou et al. show that Rnd G proteins demonstrate an alternative regulation
mechanism by binding to 14-3-3 proteins through a C-terminal hybrid motif that includes adjacent
phosphorylated serine and prenylated cysteine groups. 14-3-3 inhibits Rnd proteins by extracting
them from their site of action on membranes, which is regulated by Rnd phosphorylation.Cell 153, April 25, 2013 ª2013 Elsevier Inc. 497
